+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Testing Market - Global Forecast 2026-2032- Product Image
Drug Testing Market - Global Forecast 2026-2032- Product Image
New

Drug Testing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 182 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6082432
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The drug testing market is rapidly evolving as organizations across clinical, occupational, and forensic spheres seek more accurate, defensible, and timely testing solutions. Increased regulatory demands and operational complexities are driving a new wave of analytical innovation and workflow integration for stakeholders worldwide.

Market Snapshot

The Drug Testing Market grew from USD 13.69 billion in 2025 to USD 14.40 billion in 2026. It is expected to continue growing at a CAGR of 5.43%, reaching USD 19.83 billion by 2032.

Scope & Segmentation

  • Specimen Modalities: Blood (with plasma and serum distinctions), Hair (separated into body and scalp), Oral Fluid (stimulated and unstimulated), Sweat (for niche monitoring), and Urine (24-hour or spot collections).
  • Analytical Technologies: Chromatography (gas, liquid), Immunoassay approaches (Elisa, point-of-care), Mass Spectrometry (Maldi, Tandem MS), and Spectroscopy (FTIR, UV spectroscopy).
  • Test Objectives: Health screening, post-accident assessment, pre-employment checks, random testing (including alcohol-specific protocols), and rehabilitation monitoring.
  • End-User Settings: Clinics, commercial laboratories (covering clinical and reference labs), forensic labs (government and private), hospitals with integrated reporting, and rehabilitation centers emphasizing longitudinal analysis.
  • Global Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific, each with distinct regulatory and operational landscapes influencing procurement and testing protocols.

Key Takeaways

  • Drug testing programs are transitioning from simple screening methods to multifaceted analyses, supporting clinical treatment, workplace safety, and legal outcomes by integrating comprehensive interpretive capabilities.
  • Analytical advancements, including high-resolution mass spectrometry and diversified immunoassay platforms, are expanding substance detection and lowering concentration thresholds, while streamlining workflows between centralized labs and point-of-care settings.
  • Stakeholders face increasing pressure to balance rapid turnaround with regulatory compliance and legal defensibility, prompting a shift toward digital traceability, interoperable lab information systems, and robust quality assurance procedures.
  • Procurement strategies are being redefined by supply chain disruptions and regional tariff changes. Organizations are diversifying suppliers, adopting modular instrumentation, and building local service partnerships to ensure resilience while managing operational costs.
  • Regional dynamics significantly impact laboratory practices, with differing degrees of regulatory scrutiny, accreditation expectations, and technological adoption shaping both procurement decisions and testing outcomes across markets.
  • Vendor differentiation centers on integrated offerings—such as bundled instrumentation, informatics, and end-to-end services—tailored to support both operational efficiency and ongoing accreditation requirements.

Tariff Impact

Tariff policy adjustments in the United States and other key regions are reshaping vendor selection and procurement priorities within the drug testing market. Laboratories are adapting to increased costs and longer equipment lead times by working with alternative manufacturers, reinforcing inventory management, and partnering with domestic service providers to mitigate supply chain uncertainties. This shift is improving resilience but can lead to higher short-term operational costs, requiring careful trade-off assessments by decision-makers.

Methodology & Data Sources

This report leverages a mixed-method approach that combines peer-reviewed literature, regulatory documentation, and structured interviews with laboratory leaders, clinical toxicologists, and procurement authorities. Direct input from industry professionals and validation through laboratory audits and best practice reviews underpin the credibility and practical relevance of findings.

Why This Report Matters

  • Supports strategic choices for procurement, accreditation, and workflow optimization by providing actionable, evidence-based recommendations aligned with evolving global standards.
  • Clarifies how market shifts in technology, regulation, and supply chains directly impact operational resiliency and program reliability for clinical, workplace, and forensic testing environments.

Conclusion

Integrated decisions across specimen strategy, technology adoption, and supplier partnerships are crucial for sustainable and defensible drug testing outcomes. This report empowers leaders to respond confidently to evolving regulatory and operational pressures, driving higher standards across the drug testing industry.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Drug Testing Market, by Component
8.1. Equipment
8.1.1. Immunoassay Analyzers
8.1.1.1. Benchtop Immunoassay Analyzers
8.1.1.2. High-Throughput Immunoassay Analyzers
8.1.2. Chromatography & Mass Spectrometry Instruments
8.1.2.1. GC-MS Systems
8.1.2.2. LC-MS/MS Systems
8.1.3. Rapid Test Devices
8.1.3.1. Cups
8.1.3.2. Dip Cards
8.1.3.3. Cassettes
8.1.3.4. Strips
8.2. Consumables
8.2.1. Assay Reagents & Kits
8.2.1.1. Screening Assay Kits
8.2.1.2. Confirmatory Assay Kits
8.2.2. Calibrators & Controls
8.2.3. Sample Collection Devices
8.2.3.1. Urine Collection Products
8.2.3.2. Oral Fluid Collection Products
8.2.3.3. Hair Collection Products
8.3. Software & Services
8.3.1. Laboratory Information Systems
8.3.2. Data Management & Reporting Solutions
8.3.3. Drug Testing Laboratory Services
8.3.4. Medical Review Officer & Consulting Services
8.3.5. Training & Certification Services
9. Drug Testing Market, by Sample Type
9.1. Urine
9.2. Oral Fluid
9.3. Hair
9.4. Sweat
9.5. Blood
9.6. Breath
9.7. Nail
10. Drug Testing Market, by Drug Class
10.1. Amphetamines
10.2. Cocaine
10.3. Opiates & Cannabinoids
10.4. Benzodiazepines
10.5. Barbiturates
10.6. Hallucinogens
11. Drug Testing Market, by Result Time
11.1. Rapid Results
11.1.1. Results Within Minutes
11.1.2. Same-Day Results
11.2. Standard Turnaround
11.2.1. Results Within Twenty-Four Hours
11.2.2. Results Within Two to Three Days
11.3. Extended Turnaround
12. Drug Testing Market, by Test Location
12.1. Laboratory-Based Testing
12.1.1. Centralized Reference Laboratories
12.1.2. Hospital Laboratories
12.2. Point-of-Care Testing
12.2.1. Workplace Onsite Testing
12.2.2. Clinic & Physician Office Testing
12.2.3. Emergency & First Responder Testing
12.3. Home & Remote Testing
12.3.1. Home Collection Kits
12.3.2. Telehealth-Supervised Collection
12.3.3. Mail-In Collection Kits
13. Drug Testing Market, by End User
13.1. Workplace & Corporate
13.1.1. Transportation & Logistics
13.1.2. Construction & Mining
13.1.3. Manufacturing & Industrial
13.1.4. Oil & Gas
13.1.5. Information Technology & Services
13.2. Healthcare Providers & Laboratories
13.2.1. Hospital Laboratories
13.2.2. Independent Reference Laboratories
13.2.3. Physician Office Laboratories
13.2.4. Addiction Treatment Centers
13.2.5. Clinical Toxicology Laboratories
13.3. Criminal Justice & Law Enforcement
13.3.1. Courts & Drug Courts
13.3.2. Probation & Parole Agencies
13.3.3. Prisons & Correctional Facilities
13.3.4. Police & Law Enforcement Agencies
13.4. Educational Institutions
13.4.1. Schools & Colleges
13.4.2. Universities
13.5. Sports & Athletics
13.5.1. Professional Sports Organizations
13.5.2. Collegiate & Amateur Sports Bodies
13.6. Government & Regulatory Agencies
13.7. Home Care & Personal Use
14. Drug Testing Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Drug Testing Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Drug Testing Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Drug Testing Market
18. China Drug Testing Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories
19.6. AccuBioTech Co., Ltd.
19.7. Agilent Technologies, Inc.
19.8. American Screening Corporation
19.9. Assure Tech (Hangzhou) Co., Ltd.
19.10. Bruker Corporation
19.11. Chromsystems Instruments & Chemicals GmbH
19.12. Cordant Health Solutions
19.13. Danaher Corporation
19.14. DrugScan, Inc.
19.15. Drägerwerk AG & Co. KGaA
19.16. Eurofins Scientific SE
19.17. Express Diagnostics International Inc.
19.18. F. Hoffmann-La Roche Ltd
19.19. Guangzhou Wondfo Biotech Co., Ltd.
19.20. Hangzhou Biotest Biotech Co., Ltd.
19.21. Laboratory Corporation of America Holdings
19.22. Legacy Medical Services
19.23. Lifeloc Technologies, Inc.
19.24. Mayo Clinic Laboratories
19.25. Omega Laboratories, Inc.
19.26. Oranoxis Inc.
19.27. Paramedical S.r.l.
19.28. Precision Diagnostics, LLC
19.29. Premier Biotech, Inc.
19.30. Psychemedics Corporation
19.31. Quest Diagnostics Incorporated
19.32. Randox Laboratories Ltd.
19.33. Sciteck, Inc.
19.34. Screen Italia Srl
19.35. Securetec Detektions-Systeme AG
19.36. Siemens Healthineers AG
19.37. Sonic Healthcare Limited
19.38. UCP Biosciences Inc.
19.39. United States Drug Testing Laboratories, Inc.
19.40. Zhejiang Orient Gene Biotech Co., Ltd.
List of Figures
FIGURE 1. GLOBAL DRUG TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL DRUG TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL DRUG TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL DRUG TESTING MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL DRUG TESTING MARKET SIZE, BY RESULT TIME, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DRUG TESTING MARKET SIZE, BY TEST LOCATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL DRUG TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DRUG TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL DRUG TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DRUG TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES DRUG TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA DRUG TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DRUG TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL DRUG TESTING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DRUG TESTING MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DRUG TESTING MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DRUG TESTING MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DRUG TESTING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL DRUG TESTING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL DRUG TESTING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DRUG TESTING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DRUG TESTING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DRUG TESTING MARKET SIZE, BY BENCHTOP IMMUNOASSAY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DRUG TESTING MARKET SIZE, BY BENCHTOP IMMUNOASSAY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DRUG TESTING MARKET SIZE, BY BENCHTOP IMMUNOASSAY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DRUG TESTING MARKET SIZE, BY HIGH-THROUGHPUT IMMUNOASSAY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DRUG TESTING MARKET SIZE, BY HIGH-THROUGHPUT IMMUNOASSAY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DRUG TESTING MARKET SIZE, BY HIGH-THROUGHPUT IMMUNOASSAY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY & MASS SPECTROMETRY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY & MASS SPECTROMETRY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY & MASS SPECTROMETRY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY & MASS SPECTROMETRY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DRUG TESTING MARKET SIZE, BY GC-MS SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DRUG TESTING MARKET SIZE, BY GC-MS SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DRUG TESTING MARKET SIZE, BY GC-MS SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DRUG TESTING MARKET SIZE, BY LC-MS/MS SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DRUG TESTING MARKET SIZE, BY LC-MS/MS SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DRUG TESTING MARKET SIZE, BY LC-MS/MS SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DRUG TESTING MARKET SIZE, BY RAPID TEST DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL DRUG TESTING MARKET SIZE, BY RAPID TEST DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL DRUG TESTING MARKET SIZE, BY RAPID TEST DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL DRUG TESTING MARKET SIZE, BY RAPID TEST DEVICES, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL DRUG TESTING MARKET SIZE, BY CUPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DRUG TESTING MARKET SIZE, BY CUPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DRUG TESTING MARKET SIZE, BY CUPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DRUG TESTING MARKET SIZE, BY DIP CARDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DRUG TESTING MARKET SIZE, BY DIP CARDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL DRUG TESTING MARKET SIZE, BY DIP CARDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL DRUG TESTING MARKET SIZE, BY CASSETTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DRUG TESTING MARKET SIZE, BY CASSETTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DRUG TESTING MARKET SIZE, BY CASSETTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DRUG TESTING MARKET SIZE, BY STRIPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DRUG TESTING MARKET SIZE, BY STRIPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DRUG TESTING MARKET SIZE, BY STRIPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DRUG TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DRUG TESTING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DRUG TESTING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DRUG TESTING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DRUG TESTING MARKET SIZE, BY ASSAY REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DRUG TESTING MARKET SIZE, BY ASSAY REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DRUG TESTING MARKET SIZE, BY ASSAY REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL DRUG TESTING MARKET SIZE, BY ASSAY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DRUG TESTING MARKET SIZE, BY SCREENING ASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DRUG TESTING MARKET SIZE, BY SCREENING ASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DRUG TESTING MARKET SIZE, BY SCREENING ASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DRUG TESTING MARKET SIZE, BY CONFIRMATORY ASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DRUG TESTING MARKET SIZE, BY CONFIRMATORY ASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DRUG TESTING MARKET SIZE, BY CONFIRMATORY ASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL DRUG TESTING MARKET SIZE, BY CALIBRATORS & CONTROLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DRUG TESTING MARKET SIZE, BY CALIBRATORS & CONTROLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DRUG TESTING MARKET SIZE, BY CALIBRATORS & CONTROLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE COLLECTION DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE COLLECTION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE COLLECTION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE COLLECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL DRUG TESTING MARKET SIZE, BY URINE COLLECTION PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL DRUG TESTING MARKET SIZE, BY URINE COLLECTION PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL DRUG TESTING MARKET SIZE, BY URINE COLLECTION PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL DRUG TESTING MARKET SIZE, BY ORAL FLUID COLLECTION PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL DRUG TESTING MARKET SIZE, BY ORAL FLUID COLLECTION PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL DRUG TESTING MARKET SIZE, BY ORAL FLUID COLLECTION PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL DRUG TESTING MARKET SIZE, BY HAIR COLLECTION PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL DRUG TESTING MARKET SIZE, BY HAIR COLLECTION PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL DRUG TESTING MARKET SIZE, BY HAIR COLLECTION PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL DRUG TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL DRUG TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL DRUG TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL DRUG TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL DRUG TESTING MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL DRUG TESTING MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL DRUG TESTING MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL DRUG TESTING MARKET SIZE, BY DATA MANAGEMENT & REPORTING SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL DRUG TESTING MARKET SIZE, BY DATA MANAGEMENT & REPORTING SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL DRUG TESTING MARKET SIZE, BY DATA MANAGEMENT & REPORTING SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TESTING LABORATORY SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TESTING LABORATORY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG TESTING LABORATORY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL DRUG TESTING MARKET SIZE, BY MEDICAL REVIEW OFFICER & CONSULTING SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL DRUG TESTING MARKET SIZE, BY MEDICAL REVIEW OFFICER & CONSULTING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL DRUG TESTING MARKET SIZE, BY MEDICAL REVIEW OFFICER & CONSULTING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL DRUG TESTING MARKET SIZE, BY TRAINING & CERTIFICATION SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL DRUG TESTING MARKET SIZE, BY TRAINING & CERTIFICATION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL DRUG TESTING MARKET SIZE, BY TRAINING & CERTIFICATION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL DRUG TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL DRUG TESTING MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL DRUG TESTING MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL DRUG TESTING MARKET SIZE, BY ORAL FLUID, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL DRUG TESTING MARKET SIZE, BY ORAL FLUID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL DRUG TESTING MARKET SIZE, BY ORAL FLUID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL DRUG TESTING MARKET SIZE, BY HAIR, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL DRUG TESTING MARKET SIZE, BY HAIR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL DRUG TESTING MARKET SIZE, BY HAIR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL DRUG TESTING MARKET SIZE, BY SWEAT, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL DRUG TESTING MARKET SIZE, BY SWEAT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL DRUG TESTING MARKET SIZE, BY SWEAT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL DRUG TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL DRUG TESTING MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL DRUG TESTING MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL DRUG TESTING MARKET SIZE, BY BREATH, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL DRUG TESTING MARKET SIZE, BY BREATH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL DRUG TESTING MARKET SIZE, BY BREATH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL DRUG TESTING MARKET SIZE, BY NAIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL DRUG TESTING MARKET SIZE, BY NAIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL DRUG TESTING MARKET SIZE, BY NAIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL DRUG TESTING MARKET SIZE, BY AMPHETAMINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL DRUG TESTING MARKET SIZE, BY AMPHETAMINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL DRUG TESTING MARKET SIZE, BY AMPHETAMINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL DRUG TESTING MARKET SIZE, BY COCAINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL DRUG TESTING MARKET SIZE, BY COCAINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL DRUG TESTING MARKET SIZE, BY COCAINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL DRUG TESTING MARKET SIZE, BY OPIATES & CANNABINOIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL DRUG TESTING MARKET SIZE, BY OPIATES & CANNABINOIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL DRUG TESTING MARKET SIZE, BY OPIATES & CANNABINOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL DRUG TESTING MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL DRUG TESTING MARKET SIZE, BY BENZODIAZEPINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL DRUG TESTING MARKET SIZE, BY BENZODIAZEPINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL DRUG TESTING MARKET SIZE, BY BARBITURATES, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL DRUG TESTING MARKET SIZE, BY BARBITURATES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL DRUG TESTING MARKET SIZE, BY BARBITURATES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL DRUG TESTING MARKET SIZE, BY HALLUCINOGENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL DRUG TESTING MARKET SIZE, BY HALLUCINOGENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL DRUG TESTING MARKET SIZE, BY HALLUCINOGENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL DRUG TESTING MARKET SIZE, BY RESULT TIME, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL DRUG TESTING MARKET SIZE, BY RAPID RESULTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL DRUG TESTING MARKET SIZE, BY RAPID RESULTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL DRUG TESTING MARKET SIZE, BY RAPID RESULTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL DRUG TESTING MARKET SIZE, BY RAPID RESULTS, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL DRUG TESTING MARKET SIZE, BY RESULTS WITHIN MINUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL DRUG TESTING MARKET SIZE, BY RESULTS WITHIN MINUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL DRUG TESTING MARKET SIZE, BY RESULTS WITHIN MINUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL DRUG TESTING MARKET SIZE, BY SAME-DAY RESULTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL DRUG TESTING MARKET SIZE, BY SAME-DAY RESULTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL DRUG TESTING MARKET SIZE, BY SAME-DAY RESULTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL DRUG TESTING MARKET SIZE, BY STANDARD TURNAROUND, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL DRUG TESTING MARKET SIZE, BY STANDARD TURNAROUND, BY GROUP, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL DRUG TESTING MARKET SIZE, BY STANDARD TURNAROUND, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL DRUG TESTING MARKET SIZE, BY STANDARD TURNAROUND, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL DRUG TESTING MARKET SIZE, BY RESULTS WITHIN TWENTY-FOUR HOURS, BY REGION, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL DRUG TESTING MARKET SIZE, BY RESULTS WITHIN TWENTY-FOUR HOURS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL DRUG TESTING MARKET SIZE, BY RESULTS WITHIN TWENTY-FOUR HOURS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL DRUG TESTING MARKET SIZE, BY RESULTS WITHIN TWO TO THREE DAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL DRUG TESTING MARKET SIZE, BY RESULTS WITHIN TWO TO THREE DAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL DRUG TESTING MARKET SIZE, BY RESULTS WITHIN TWO TO THREE DAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL DRUG TESTING MARKET SIZE, BY EXTENDED TURNAROUND, BY REGION, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL DRUG TESTING MARKET SIZE, BY EXTENDED TURNAROUND, BY GROUP, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL DRUG TESTING MARKET SIZE, BY EXTENDED TURNAROUND, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL DRUG TESTING MARKET SIZE, BY TEST LOCATION, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL DRUG TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL DRUG TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL DRUG TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL DRUG TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL DRUG TESTING MARKET SIZE, BY CENTRALIZED REFERENCE LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL DRUG TESTING MARKET SIZE, BY CENTRALIZED REFERENCE LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL DRUG TESTING MARKET SIZE, BY CENTRALIZED REFERENCE LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL DRUG TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL DRUG TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL DRUG TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL DRUG TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL DRUG TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL DRUG TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL DRUG TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL DRUG TESTING MARKET SIZE, BY WORKPLACE ONSITE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL DRUG TESTING MARKET SIZE, BY WORKPLACE ONSITE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL DRUG TESTING MARKET SIZE, BY WORKPLACE ONSITE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL DRUG TESTING MARKET SIZE, BY CLINIC & PHYSICIAN OFFICE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL DRUG TESTING MARKET SIZE, BY CLINIC & PHYSICIAN OFFICE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL DRUG TESTING MARKET SIZE, BY CLINIC & PHYSICIAN OFFICE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL DRUG TESTING MARKET SIZE, BY EMERGENCY & FIRST RESPONDER TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL DRUG TESTING MARKET SIZE, BY EMERGENCY & FIRST RESPONDER TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL DRUG TESTING MARKET SIZE, BY EMERGENCY & FIRST RESPONDER TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL DRUG TESTING MARKET SIZE, BY HOME & REMOTE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL DRUG TESTING MARKET SIZE, BY HOME & REMOTE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL DRUG TESTING MARKET SIZE, BY HOME & REMOTE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL DRUG TESTING MARKET SIZE, BY HOME & REMOTE TESTING, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL DRUG TESTING MARKET SIZE, BY HOME COLLECTION KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL DRUG TESTING MARKET SIZE, BY HOME COLLECTION KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL DRUG TESTING MARKET SIZE, BY HOME COLLECTION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL DRUG TESTING MARKET SIZE, BY TELEHEALTH-SUPERVISED COLLECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL DRUG TESTING MARKET SIZE, BY TELEHEALTH-SUPERVISED COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL DRUG TESTING MARKET SIZE, BY TELEHEALTH-SUPERVISED COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL DRUG TESTING MARKET SIZE, BY MAIL-IN COLLECTION KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL DRUG TESTING MARKET SIZE, BY MAIL-IN COLLECTION KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL DRUG TESTING MARKET SIZE, BY MAIL-IN COLLECTION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL DRUG TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL DRUG TESTING MARKET SIZE, BY WORKPLACE & CORPORATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL DRUG TESTING MARKET SIZE, BY WORKPLACE & CORPORATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL DRUG TESTING MARKET SIZE, BY WORKPLACE & CORPORATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL DRUG TESTING MARKET SIZE, BY WORKPLACE & CORPORATE, 2018-2032 (USD MILLION)
TABLE 199. GLOBAL DRUG TESTING MARKET SIZE, BY TRANSPORTATION & LOGISTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL DRUG TESTING MARKET SIZE, BY TRANSPORTATION & LOGISTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL DRUG TESTING MARKET SIZE, BY TRANSPORTATION & LOGISTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. GLOBAL DRUG TESTING MARKET SIZE, BY CONSTRUCTION & MINING, BY REGION, 2018-2032 (USD MILLION)
TABLE 203. GLOBAL DRUG TESTING MARKET SIZE, BY CONSTRUCTION & MINING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 204. GLOBAL DRUG TESTING MARKET SIZE, BY CONSTRUCTION & MINING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. GLOBAL DRUG TESTING MARKET SIZE, BY MANUFACTURING & INDUSTRIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 206. GLOBAL DRUG TESTING MARKET SIZE, BY MANUFACTURING & INDUSTRIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 207. GLOBAL DRUG TESTING MARKET SIZE, BY MANUFACTURING & INDUSTRIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. GLOBAL DRUG TESTING MARKET SIZE, BY OIL & GAS, BY REGION, 2018-2032 (USD MILLION)
TABLE 209. GLOBAL DRUG TESTING MARKET SIZE, BY OIL & GAS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 210. GLOBAL DRUG TESTING MARKET SIZE, BY OIL & GAS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. GLOBAL DRUG TESTING MARKET SIZE, BY INFORMATION TECHNOLOGY & SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 212. GLOBAL DRUG TESTING MARKET SIZE, BY INFORMATION TECHNOLOGY & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 213. GLOBAL DRUG TESTING MARKET SIZE, BY INFORMATION TECHNOLOGY & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. GLOBAL DRUG TESTING MARKET SIZE, BY HEALTHCARE PROVIDERS & LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 215. GLOBAL DRUG TESTING MARKET SIZE, BY HEALTHCARE PROVIDERS & LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 216. GLOBAL DRUG TESTING MARKET SIZE, BY HEALTHCARE PROVIDERS & LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. GLOBAL DRUG TESTING MARKET SIZE, BY HEALTHCARE PROVIDERS & LABORATORIES, 2018-2032 (USD MILLION)
TABLE 218. GLOBAL DRUG TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 219. GLOBAL DRUG TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 220. GLOBAL DRUG TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 221. GLOBAL DRUG TESTING MARKET SIZE, BY INDEPENDENT REFERENCE LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 222. GLOBAL DRUG TESTING MARKET SIZE, BY INDEPENDENT REFERENCE LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 223. GLOBAL DRUG TESTING MARKET SIZE, BY INDEPENDENT REFERENCE LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 224. GLOBAL DRUG TESTING MARKET SIZE, BY PHYSICIAN OFFICE LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 225. GLOBAL DRUG TESTING MARKET SIZE, BY PHYSICIAN OFFICE LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 226. GLOBAL DRUG TESTING MARKET SIZE, BY PHYSICIAN OFFICE LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 227. GLOBAL DRUG TESTING MARKET SIZE, BY ADDICTION TREATMENT CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 228. GLOBAL DRUG TESTING MARKET SIZE, BY ADDICTION TREATMENT CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 229. GLOBAL DRUG TESTING MARKET SIZE, BY ADDICTION TREATMENT CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 230. GLOBAL DRUG TESTING MARKET SIZE, BY CLINICAL TOXICOLOGY LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 231. GLOBAL DRUG TESTING MARKET SIZE, BY CLINICAL TOXICOLOGY LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 232. GLOBAL DRUG TESTING MARKET SIZE, BY CLINICAL TOXICOLOGY LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 233. GLOBAL DRUG TESTING MARKET SIZE, BY CRIMINAL JUSTICE & LAW ENFORCEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 234. GLOBAL DRUG TESTING MARKET SIZE, BY CRIMINAL JUSTICE & LAW ENFORCEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 235. GLOBAL DRUG TESTING MARKET SIZE, BY CRIMINAL JUSTICE & LAW ENFORCEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 236. GLOBAL DRUG TESTING MARKET SIZE, BY CRIMINAL JUSTICE & LAW ENFORCEMENT, 2018-2032 (USD MILLION)
TABLE 237. GLOBAL DRUG TESTING MARKET SIZE, BY COURTS & DRUG COURTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 238. GLOBAL DRUG TESTING MARKET SIZE, BY COURTS & DRUG COURTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 239. GLOBAL DRUG TESTING MARKET SIZE, BY COURTS & DRUG COURTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 240. GLOBAL DRUG TESTING MARKET SIZE, BY PROBATION & PAROLE AGENCIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 241. GLOBAL DRUG TESTING MARKET SIZE, BY PROBATION & PAROLE AGENCIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 242. GLOBAL DRUG TESTING MARKET SIZE, BY PROBATION & PAROLE AGENCIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 243. GLOBAL DRUG TESTING MARKET SIZE, BY PRISONS & CORRECTIONAL FACILITIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 244. GLOBAL DRUG TESTING MARKET SIZE, BY PRISONS & CORRECTIONAL FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 245. GLOBAL DRUG TESTING MARKET SIZE, BY PRISONS & CORRECTIONAL FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 246. GLOBAL DRUG TESTING MARKET SIZE, BY POLICE & LAW ENFORCEMENT AGENCIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 247. GLOBAL DRUG TESTING MARKET SIZE, BY POLICE & LAW ENFORCEMENT AGENCIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 248. GLOBAL DRUG TESTING MARKET SIZE, BY POLICE & LAW ENFORCEMENT AGENCIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 249. GLOBAL DRUG TESTING MARKET SIZE, BY EDUCATIONAL INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 250. GLOBAL DRUG TESTING MARKET SIZE, BY EDUCATIONAL INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 251. GLOBAL DRUG TESTING MARKET SIZE, BY EDUCATIONAL INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 252. GLOBAL DRUG TESTING MARKET SIZE, BY EDUCATIONAL INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 253. GLOBAL DRUG TESTING MARKET SIZE, BY SCHOOLS & COLLEGES, BY REGION, 2018-2032 (USD MILLION)
TABLE 254. GLOBAL DRUG TESTING MARKET SIZE, BY SCHOOLS & COLLEGES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 255. GLOBAL DRUG TESTING MARKET SIZE, BY SCHOOLS & COLLEGES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 256. GLOBAL DRUG TESTING MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 257. GLOBAL DRUG TESTING MARKET SIZE, BY UNIVERSITIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 258. GLOBAL DRUG TESTING MARKET SIZE, BY UNIVERSITIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. GLOBAL DRUG TESTING MARKET SIZE, BY SPORTS & ATHLETICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 260. GLOBAL DRUG TESTING MARKET SIZE, BY SPORTS & ATHLETICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 261. GLOBAL DRUG TESTING MARKET SIZE, BY SPORTS & ATHLETICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 262. GLOBAL DRUG TESTING MARKET SIZE, BY SPORTS & ATHLETICS, 2018-2032 (USD MILLION)
TABLE 263. GLOBAL DRUG TESTING MARKET SIZE, BY PROFESSIONAL SPORTS ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 264. GLOBAL DRUG TESTING MARKET SIZE, BY PROFESSIONAL SPORTS ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 265. GLOBAL DRUG TESTING MARKET SIZE, BY PROFESSIONAL SPORTS ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 266. GLOBAL DRUG TESTING MARKET SIZE, BY COLLEGIATE & AMATEUR SPORTS BODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 267. GLOBAL DRUG TESTING MARKET SIZE, BY COLLEGIATE & AMATEUR SPORTS BODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 268. GLOBAL DRUG TESTING MARKET SIZE, BY COLLEGIATE & AMATEUR SPORTS BODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 269. GLOBAL DRUG TESTING MARKET SIZE, BY GOVERNMENT & REGULATORY AGENCIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 270. GLOBAL DRUG TESTING MARKET SIZE, BY GOVERNMENT & REGULATORY AGENCIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 271. GLOBAL DRUG TESTING MARKET SIZE, BY GOVERNMENT & REGULATORY AGENCIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 272. GLOBAL DRUG TESTING MARKET SIZE, BY HOME CARE & PERSONAL USE, BY REGION, 2018-2032 (USD MILLION)
TABLE 273. GLOBAL DRUG TESTING MARKET SIZE, BY HOME CARE & PERSONAL USE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 274. GLOBAL DRUG TESTING MARKET SIZE, BY HOME CARE & PERSONAL USE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 275. GLOBAL DRUG TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 276. AMERICAS DRUG TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 277. AMERICAS DRUG TESTING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 278. AMERICAS DRUG TESTING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 279. AMERICAS DRUG TESTING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, 2018-2032 (USD MILLION)
TABLE 280. AMERICAS DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY & MASS SPECTROMETRY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 281. AMERICAS DRUG TESTING MARKET SIZE, BY RAPID TEST DEVICES, 2018-2032 (USD MILLION)
TABLE 282. AMERICAS DRUG TESTING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 283. AMERICAS DRUG TESTING MARKET SIZE, BY ASSAY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 284. AMERICAS DRUG TESTING MARKET SIZE, BY SAMPLE COLLECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 285. AMERICAS DRUG TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 286. AMERICAS DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 287. AMERICAS DRUG TESTING MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 288. AMERICAS DRUG TESTING MARKET SIZE, BY RESULT TIME, 2018-2032 (USD MILLION)
TABLE 289. AMERICAS DRUG TESTING MARKET SIZE, BY RAPID RESULTS, 2018-2032 (USD MILLION)
TABLE 290. AMERICAS DRUG TESTING MARKET SIZE, BY STANDARD TURNAROUND, 2018-2032 (USD MILLION)
TABLE 291. AMERICAS DRUG TESTING MARKET SIZE, BY TEST LOCATION, 2018-2032 (USD MILLION)
TABLE 292. AMERICAS DRUG TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 293. AMERICAS DRUG TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2032 (USD MILLION)
TABLE 294. AMERICAS DRUG TESTING MARKET SIZE, BY HOME & REMOTE TESTING, 2018-2032 (USD MILLION)
TABLE 295. AMERICAS DRUG TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 296. AMERICAS DRUG TESTING MARKET SIZE, BY WORKPLACE & CORPORATE, 2018-2032 (USD MILLION)
TABLE 297. AMERICAS DRUG TESTING MARKET SIZE, BY HEALTHCARE PROVIDERS & LABORATORIES, 2018-2032 (USD MILLION)
TABLE 298. AMERICAS DRUG TESTING MARKET SIZE, BY CRIMINAL JUSTICE & LAW ENFORCEMENT, 2018-2032 (USD MILLION)
TABLE 299. AMERICAS DRUG TESTING MARKET SIZE, BY EDUCATIONAL INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 300. AMERICAS DRUG TESTING MARKET SIZE, BY SPORTS & ATHLETICS, 2018-2032 (USD MILLION)
TABLE 301. NORTH AMERICA DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 302. NORTH AMERICA DRUG TESTING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 303. NORTH AMERICA DRUG TESTING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 304. NORTH AMERICA DRUG TESTING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, 2018-2032 (USD MILLION)
TABLE 305. NORTH AMERICA DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY & MASS SPECTROMETRY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 306. NORTH AMERICA DRUG TESTING MARKET SIZE, BY RAPID TEST DEVICES, 2018-2032 (USD MILLION)
TABLE 307. NORTH AMERICA DRUG TESTING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 308. NORTH AMERICA DRUG TESTING MARKET SIZE, BY ASSAY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 309. NORTH AMERICA DRUG TESTING MARKET SIZE, BY SAMPLE COLLECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 310. NORTH AMERICA DRUG TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 311. NORTH AMERICA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 312. NORTH AMERICA DRUG TESTING MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 313. NORTH AMERICA DRUG TESTING MARKET SIZE, BY RESULT TIME, 2018-2032 (USD MILLION)
TABLE 314. NORTH AMERICA DRUG TESTING MARKET SIZE, BY RAPID RESULTS, 2018-2032 (USD MILLION)
TABLE 315. NORTH AMERICA DRUG TESTING MARKET SIZE, BY STANDARD TURNAROUND, 2018-2032 (USD MILLION)
TABLE 316. NORTH AMERICA DRUG TESTING MARKET SIZE, BY TEST LOCATION, 2018-2032 (USD MILLION)
TABLE 317. NORTH AMERICA DRUG TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 318. NORTH AMERICA DRUG TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2032 (USD MILLION)
TABLE 319

Companies Mentioned

The key companies profiled in this Drug Testing market report include:
  • Abbott Laboratories
  • AccuBioTech Co., Ltd.
  • Agilent Technologies, Inc.
  • American Screening Corporation
  • Assure Tech (Hangzhou) Co., Ltd.
  • Bruker Corporation
  • Chromsystems Instruments & Chemicals GmbH
  • Cordant Health Solutions
  • Danaher Corporation
  • DrugScan, Inc.
  • Drägerwerk AG & Co. KGaA
  • Eurofins Scientific SE
  • Express Diagnostics International Inc.
  • F. Hoffmann-La Roche Ltd
  • Guangzhou Wondfo Biotech Co., Ltd.
  • Hangzhou Biotest Biotech Co., Ltd.
  • Laboratory Corporation of America Holdings
  • Legacy Medical Services
  • Lifeloc Technologies, Inc.
  • Mayo Clinic Laboratories
  • Omega Laboratories, Inc.
  • Oranoxis Inc.
  • Paramedical S.r.l.
  • Precision Diagnostics, LLC
  • Premier Biotech, Inc.
  • Psychemedics Corporation
  • Quest Diagnostics Incorporated
  • Randox Laboratories Ltd.
  • Sciteck, Inc.
  • Screen Italia Srl
  • Securetec Detektions-Systeme AG
  • Siemens Healthineers AG
  • Sonic Healthcare Limited
  • UCP Biosciences Inc.
  • United States Drug Testing Laboratories, Inc.
  • Zhejiang Orient Gene Biotech Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages182
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 14.4 Billion
Forecasted Market Value ( USD ) by 2032 $ 19.83 Billion
Compound Annual Growth Rate5.4%
Regions CoveredGlobal
No. of Companies Mentioned37

Related Topics

Related Reports

Drug of Abuse Testing Market - Global Forecast 2026-2032 - Product Image

Drug of Abuse Testing Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Urine & Oral Fluid Drug Tests Market - Global Forecast 2026-2032 - Product Image

Urine & Oral Fluid Drug Tests Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Drugs of Abuse (DOA) Testing Market Report 2025 - Product Image

Drugs of Abuse (DOA) Testing Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Hair Drug Testing Global Market Report 2025 - Product Image

Hair Drug Testing Global Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Employer and Workplace Drug Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Employer and Workplace Drug Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.